Source: Arysta LifeScience news release
Wheat farmers now have a new systemic, broad-spectrum fungicide for stronger plant health and higher yields. Arysta LifeScience recently announced that the U.S. Environmental Protection Agency (EPA) has approved ZOLERA FX Fungicide for use in wheat production.
“ZOLERA FX has earned a reputation as a trusted ally for effective disease control in corn and soybean production,” says Royce Schulte, BioSolutions and Innovative Nutrition Business Manager, Arysta LifeScience. “Arysta LifeScience is pleased to report that ZOLERA FX is now available in wheat, providing growers an effective new tool to protect their crop investment and build healthier wheat plants that yield stronger.”
The fungicide combines fluoxastrobin, a fast-acting, highly systemic strobilurin, with tetraconazole, a highly systemic triazole. In both early season and flag leaf applications, it’s effective against Stripe rust, Leaf rust, Tan spot, Spot blotch, Septoria leaf and glume blotch and other diseases.
Featuring the best plant uptake and mobility within the plant for maximum plant coverage, ZOLERA FX brings multiple modes of action in a single application for stronger plant health plus preventative and curative disease control. In 18 replicated herbicide trials at herbicide timing (Feekes 2-5), ZOLERA FX provided a 4 bu/A yield increase over nontreated fields. In similar studies at flag leaf timing, ZOLERA FX provided a strong 9 bu/A yield increase over untreated fields.
“Our studies are showing that a smart investment in disease control and plant health will pay off for wheat growers,” Schulte says. “An application of ZOLERA FX at herbicide or flag leaf timing can lead to higher yields and a greater profit potential.”